For many years, mitochondria were described in simple terms as the “ powerhouses ” of the cell. That idea is useful, but it is only part of the story. Modern science shows that mitochondria differ not only in quantity, but also in quality, location, and function across tissues. Different organs do different kinds of work, so they rely on mitochondria in different ways. The heart and skeletal muscles depend on them for continuous force production, calcium handling, and high-speed ATP turnover. The brain uses them for a different kind of labor: signaling, ion pumping, membrane potential maintenance, axonal transport, and synaptic activity . The kidney and liver also have their own specialized energy demands, shaped by filtration, transport, detoxification, and metabolism. This means that the old formula — “more work means more mitochondria” — is only partly true. It is a helpful first approximation, but it does not explain the full picture. A tissue may have many mitochondria, but tho...

  Atherosclerosis is, in a very real sense, as old as humanity itself. Archaeological studies of ancient mummies have found arterial plaques in people who lived thousands of years ago, long before fast food or sedentary lifestyles. This tells us something important: the early stages of atherosclerosis are not a disease. They are a normal part of biological aging, as universal and inevitable as greying hair or slowing reflexes. From the first decade of life, small lipid deposits — fatty streaks — begin forming quietly beneath the inner lining of our arteries. These are not inert accumulations. When these deposits begin to damage the vascular intima , the body recognizes the injury and mounts an inflammatory response . Since it cannot eliminate the lipid deposits, it does the next best thing: it encapsulates them in connective tissue, forming plaques. This is the body's compensatory mechanism — isolating what it cannot remove, much like a bee colony encasing an intruding mouse in ...

Migraine is increasingly understood not as a purely vascular problem, but as a disorder of brain functional systems . That shift matters because it changes the question from “what causes the pain?” to “how does the brain organize, sustain, and fail to shut off the migraine state?” In other words, migraine may be less about a single vessel or isolated symptom and more about a dynamic, self-reinforcing network disturbance involving multiple brain systems at once. A useful way to frame this is through the logic of functional systems: reference point, internal model, and action-learning. The reference point is what the system treats as important or threatening. The internal model is how the brain interprets the situation, predicts what is happening, and anticipates the next step. Action-learning is the loop through which the system responds, receives feedback, and either adapts or becomes stuck. In migraine, these components may become dysregulated so that normal sensory input, stress, sle...

   In a "normal" country, danger is an event. It has a beginning and an end, a place where it happened, and people whom it directly affected. Grief is permitted to follow a shape: shock, then acknowledgment, then — however slowly — something resembling return. In a country without a rear, danger turns into background. It is always present, even when, at this very moment, no one is firing. It cannot be "switched off" — it only changes form. Physical danger arrives through sirens, explosions, power cuts, the movement of military vehicles, news of new strikes. Informational danger flows through news feeds, air-raid alert channels, chats where messages about shelling and losses appear earlier than any official report. Even when the body is in a relatively safe place, the psyche lives in a mode of "anything can happen at any moment." For sleep, this means that the boundary between "day" and "night" blurs, and the night loses its ancient stat...

Longevity escape velocity is commonly described as a hypothetical point at which biomedical progress extends a person’s remaining life expectancy faster than time passes. In that model, medicine would no longer simply delay disease or death in the ordinary sense, but would begin to offset the damage of aging quickly enough that further survival continually opens the possibility of further extension. This idea has become influential in contemporary longevity discourse, but it remains a hypothesis about future medicine rather than an established scientific achievement.  One of the main reasons for caution is conceptual. The evidence most often cited in support of radical longevity usually concerns average survival rather than the verified upper boundary of human life. Over the modern era, life expectancy has risen dramatically because more people survive infection, trauma, maternal and infant mortality, and chronic disease. These gains demonstrate that medicine and public health hav...

   The modern debate about artificial intelligence is built around a familiar image, even when it is not named directly. It is the image of a trap. Humanity constructs something powerful, releases it into the world, and then fears being caught by its own invention. AI is the mousetrap. Humanity is the mouse approaching the mechanism it designed but may no longer control. This image has serious intellectual sponsors. Nick Bostrom argued that a system surpassing human cognitive capacity will pursue its objectives with an indifference to human survival that looks, from our side, indistinguishable from hostility. Yuval Noah Harari arrived at a structurally related conclusion: that AI and biotechnology together may produce, for the first time in history, a class of people rendered not merely exploited but economically and cognitively useless. The language of these warnings differs. The underlying fear is the same: humanity built something that may not need us. But both thinkers...

  Robust Mouse Rejuvenation 1 (RMR1 - https://www.levf.org/breaking-the-ceiling-of-longevity-research ) is a rigorous and distinctive study that tests whether several late-life interventions can act together in mice rather than in isolation. Its value lies in the scale of the experiment, the ambition of the design, and the attempt to move beyond single-therapy thinking toward combinatorial rejuvenation . RMR1 used 1,000 C57BL/6J mice divided into 10 groups per sex, with treatment beginning at approximately 19 months of age. The study tested combinations of rapamycin , senolytics , telomerase gene therapy , and hematopoietic stem cell transplantation , with an explicit aim to extend both mean and maximum lifespan by at least 12 months. The authors described the outcome as a "qualified win," reporting additive benefits of damage-repair treatments and clearer understanding of how interventions behave in combination. However, they also stated that they did not observe a radica...